Recent Blog Posts

View Post: Reductil Sibutramine for Obesity Treatment and Slimming
28 Nov 2009 by Cure Anxiety  
http://www.articlesbase.com/medicine-articles/reductil-sibutramine-for-obesity-treatment-and-slimming-675212.html. Similar Posts: Types of Anxiety Attack Medication; Good Supplement Suggestions to Combat Anxiety; The Best Types of ...
View Blog: Treatment For Anxiety - http://www.treatment-for-anxiety.org/

---

View Post: Obesity drug Meridia (sibutramine) could cause heart disease: US ...
23 Nov 2009 by pillscribe  
Sibutramine (Meridia's) efficacy as a weight loss treatment was examined in 11 double-blind, placebo-controlled obesity trials with study durations of 12 to 52 weeks and doses ranging from 1 to 30 mg once daily. ...
View Blog: DWS Pill Scribe - http://www.dancewithshadows.com/pillscribe/

---

View Post: EMEA starts sibutramine review, as FDA investigates Meridia ...
23 Nov 2009
The European Medicines Agency (EMEA) says it has started a review of sibutramine-containing anti-obesity medicines (marketed in Europe under trade names such as Reductil, Zelium, Reduxade), because preliminary data suggest a possible ...
View Blog: thepharmaletter.com - http://www.thepharmaletter.com/

---

View Post: FDA to evaluate risk of cardiovascular events with sibutramine - MPR
23 Nov 2009
Sibutramine is indicated as an adjunct to diet in the management of obesity in patients with initial body mass index ≥30kg/m2, or ≥27kg/m2 in presence of other risk factors. For more information visit ...
View Blog: Latest articles from MPR - http://www.empr.com/

---

View Post: Meridia, Reductil, SCOUT, obesity
23 Nov 2009
[HeartWire > News; Oct 31, 2007]; AHA issues scientific statement on obesity [HeartWire > News; Oct 25, 2004]; FDA issues warning letter to Abbott over faulty adverse events reporting for sibutramine [HeartWire > News; Aug 08, 2002] ...
View Blog: theHeart.org - http://www.theheart.org/

---

View Post: FDA MedWatch – Meridia (sibutramine): Early Communication about ...
23 Nov 2009 by irbtipoftheweek  
Sibutramine is marketed as Meridia, a prescription drug, in the United States. Meridia was approved by FDA in 1997 for the management of obesity, including weight loss and maintenance of weight loss, in conjunction with a reduced ...
View Blog: Vanderbilt IRB News - http://irbtipoftheweek.wordpress.com/

---

View Post: EMEA investigating increased cardiovascular risk with sibutramine ...
20 Nov 2009 by Larry Husten  
The Committee started a safety review of anti-obesity medicines containing sibutramine, because preliminary data suggest a possible increased risk of serious cardiovascular events. The data raising the concern come from the SCOUT study ...
View Blog: CardioBrief - http://cardiobrief.org/

---

View Post: Life and Style
The Independent UK - The decade that changed medicine
21 hours ago by The Independent   ...
View Blog: http://lifeandstyle.independentminds.livejournal.com/

---

View Post: What is the Role of Drug Therapy in Treating Obesity?
Clinical ...
19 Nov 2009 by Clinical Correlations   ...
View Blog: http://www.clinicalcorrelations.org/

---